Literature DB >> 21567981

Synaptic defects in spinal muscular atrophy animal models.

Laura Torres-Benito1, Rocío Ruiz, Lucía Tabares.   

Abstract

Proximal spinal muscular atrophy, the most frequent genetic cause of childhood lethality, is caused by homozygous loss or mutation of the SMN1 gene on human chromosome 5, which codes for the survival motor neuron (SMN) protein. SMN plays a role in the assembly of small nuclear ribonucleoproteins and, additionally, in synaptic function. SMN deficiency produces defects in motor neuron β-actin mRNA axonal transport, neurofilament dynamics, neurotransmitter release, and synapse maturation. The underlying molecular mechanisms and, in particular, the role of the cytoskeleton on the pathogenesis of this disease are starting to be revealed.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21567981     DOI: 10.1002/dneu.20912

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  16 in total

1.  The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.

Authors:  Seyyedmohsen Hosseinibarkooie; Miriam Peters; Laura Torres-Benito; Raphael H Rastetter; Kristina Hupperich; Andrea Hoffmann; Natalia Mendoza-Ferreira; Anna Kaczmarek; Eva Janzen; Janine Milbradt; Tobias Lamkemeyer; Frank Rigo; C Frank Bennett; Christoph Guschlbauer; Ansgar Büschges; Matthias Hammerschmidt; Markus Riessland; Min Jeong Kye; Christoph S Clemen; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

2.  Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.

Authors:  Naresh K Genabai; Saif Ahmad; Zhanying Zhang; Xiaoting Jiang; Cynthia A Gabaldon; Laxman Gangwani
Journal:  Hum Mol Genet       Date:  2015-09-30       Impact factor: 6.150

3.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

4.  Neurotransmitter release in motor nerve terminals of a mouse model of mild spinal muscular atrophy.

Authors:  Rocío Ruiz; Lucía Tabares
Journal:  J Anat       Date:  2013-03-13       Impact factor: 2.610

Review 5.  The role of laminins in the organization and function of neuromuscular junctions.

Authors:  Robert S Rogers; Hiroshi Nishimune
Journal:  Matrix Biol       Date:  2016-09-07       Impact factor: 11.583

6.  Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy.

Authors:  Kornelia Neveling; Lilian A Martinez-Carrera; Irmgard Hölker; Angelien Heister; Aad Verrips; Seyyed Mohsen Hosseini-Barkooie; Christian Gilissen; Sascha Vermeer; Maartje Pennings; Rowdy Meijer; Margot te Riele; Catharina J M Frijns; Oksana Suchowersky; Linda MacLaren; Sabine Rudnik-Schöneborn; Richard J Sinke; Klaus Zerres; R Brian Lowry; Henny H Lemmink; Lutz Garbes; Joris A Veltman; Helenius J Schelhaas; Hans Scheffer; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

7.  α-COP binding to the survival motor neuron protein SMN is required for neuronal process outgrowth.

Authors:  Hongxia Li; Sara K Custer; Timra Gilson; Le Thi Hao; Christine E Beattie; Elliot J Androphy
Journal:  Hum Mol Genet       Date:  2015-10-13       Impact factor: 5.121

8.  Presynaptic localization of Smn and hnRNP R in axon terminals of embryonic and postnatal mouse motoneurons.

Authors:  Benjamin Dombert; Rajeeve Sivadasan; Christian M Simon; Sibylle Jablonka; Michael Sendtner
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

Review 9.  Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy.

Authors:  Marina Boido; Alessandro Vercelli
Journal:  Front Neuroanat       Date:  2016-02-03       Impact factor: 3.856

10.  Gain-of-function mutations in the ALS8 causative gene VAPB have detrimental effects on neurons and muscles.

Authors:  Mario Sanhueza; Luigi Zechini; Trudy Gillespie; Giuseppa Pennetta
Journal:  Biol Open       Date:  2014-01-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.